Engineering of a VPAC2 Receptor Peptide Agonist to Impart Dipeptidyl Peptidase IV Stability and Enhance in Vivo Glucose Disposal

doi 10.1021/jm0609059.s001

Full Text

Abstract

Available in

Date

Unknown

Authors

Unknown

Publisher

American Chemical Society (ACS)

Related search

Wound Healing Process and Dipeptidyl Peptidase IV

Medicina fluminensis

English

A Potent and Highly Selective VPAC2 Agonist Enhances Glucose-Induced Insulin Release and Glucose Disposal: A Potential Therapy for Type 2 Diabetes

Internal Medicine

English

Discovery of Dipeptidyl-Peptidase IV—a 40 Year Journey From Bench to Patient

Internal Medicine

English

Distribution of Dipeptidyl Peptidase IV in Patients With Chronic Tonsillitis

Clinical and Vaccine Immunology

Clinical Biochemistry

English

Discovery of Food-Derived Dipeptidyl Peptidase IV Inhibitory Peptides: A Review

International Journal of Molecular Sciences

Organic Chemistry

Molecular Biology

Theoretical Chemistry

Inorganic Chemistry

Computer Science Applications

Indonesian

Design and Discovery of a Novel Dipeptidyl-Peptidase IV (CD26)-Based Prodrug Approach

English

Glucagon-Like Peptide-1 (GLP-1) Mediates the Protective Effects of Dipeptidyl Peptidase IV Inhibition on Pulmonary Hypertension

Journal of Biomedical Science

Clinical Biochemistry

Molecular Biology

English

Pyrazolidine Derivatives With Heteroaryl Urea as Dipeptidyl Peptidase IV Inhibitors

Chemical and Pharmaceutical Bulletin

English

Dipeptidyl Peptidase IV and Incident Diabetes: The Atherosclerosis Risk in Communities (ARIC) Study

Internal Medicine

Specialized Nursing

English